EU alert to below threshold pharma deals that hurt competition, official says
The EU’s antitrust watchdog is keeping an eye out for acquisitions in the pharmaceutical sector that could hurt competition even though they are below the threshold for a merger review, an...To view the full article, register now.
Already a subscriber? Click here to view full article